美股異動 | 金佰利漲9% 2022年前景樂觀 季度收益強勁
格隆匯4月22日丨金佰利(KMB.US)漲9.18%,報139.86美元,總市值471億美元。儘管存在通脹,但該公司公佈的收益好於預期,並表示預計2022年全年收入將增加。金佰利公佈截至3月份的季度營收為51億美元,比去年同期增長7%,其中營收增長10%,根據FactSet分析師預計營收為49億美元。該公司表示,目前預計今年營收將增長2%至4%,而此前的預測為1%至2%。管理層表示,有機產品的銷售額將增長4%至6%,而此前的預測為3%至4%。在通貨膨脹的影響下,預計2022年的淨銷售價格將更高。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.